Tryptophan degradation in patients with gynecological cancer correlates with immune activation
- 8 June 2005
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 223 (2), 323-329
- https://doi.org/10.1016/j.canlet.2004.10.033
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Neopterin in HIV-1 infectionMolecular Immunology, 2005
- Increasing production of homocysteine and neopterin and degradation of tryptophan with older ageClinical Biochemistry, 2004
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseNature Medicine, 2003
- Enhanced Tryptophan Degradation in Systemic Lupus ErythematosusImmunobiology, 2000
- Decreased Serum Tryptophan in Patients with Cancer Cachexia Correlates with Increased Serum NeopterinImmunological Investigations, 1995
- Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infectionImmunology Letters, 1991
- Characteristics of interferon induced tryptophan metabolism in human cells in vitroBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effectsCellular and Molecular Life Sciences, 1989
- Interferon-γ suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophanMolecular and Biochemical Parasitology, 1986
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984